Drugs . | CRRT group (n = 15) . | Furosemide group (n = 15) . | Total (n = 30) . | P . |
---|---|---|---|---|
Antibiotic medications, number (%) | ||||
Meropeneme | 13 (86.6) | 12 (80.0) | 28 (93.3) | 0.6 |
Vancomycin | 14 (93.3) | 12 (80.0) | 25 (83.3) | 0.3 |
Antifungal medications, number (%) | ||||
Nystatine | 15 (100) | 15 (100) | 30 (100) | 1 |
Antiviral medications, number (%) | ||||
Ganciclovir | 11 (73.3) | 14 (93.3) | 25 (83.3) | 0.1 |
Transplant medications, number (%) | ||||
Antithymocyte globulin | 15 (100) | 15 (100) | 30 (100) | 1 |
Tacrolimus | 15 (100) | 15 (100) | 30 (100) | 1 |
Inotropes, number (%) | 15 (100) | 15 (100) | 30 (100) | 1 |
5% dextrose in water (500 ml/m2) plus KCl (10 meq/m2) | 15 (100) | 15 (100) | 30 (100) | 1 |
Drugs . | CRRT group (n = 15) . | Furosemide group (n = 15) . | Total (n = 30) . | P . |
---|---|---|---|---|
Antibiotic medications, number (%) | ||||
Meropeneme | 13 (86.6) | 12 (80.0) | 28 (93.3) | 0.6 |
Vancomycin | 14 (93.3) | 12 (80.0) | 25 (83.3) | 0.3 |
Antifungal medications, number (%) | ||||
Nystatine | 15 (100) | 15 (100) | 30 (100) | 1 |
Antiviral medications, number (%) | ||||
Ganciclovir | 11 (73.3) | 14 (93.3) | 25 (83.3) | 0.1 |
Transplant medications, number (%) | ||||
Antithymocyte globulin | 15 (100) | 15 (100) | 30 (100) | 1 |
Tacrolimus | 15 (100) | 15 (100) | 30 (100) | 1 |
Inotropes, number (%) | 15 (100) | 15 (100) | 30 (100) | 1 |
5% dextrose in water (500 ml/m2) plus KCl (10 meq/m2) | 15 (100) | 15 (100) | 30 (100) | 1 |
CRRT: continuous renal replacement therapy; KCI: potassium chloride
Drugs . | CRRT group (n = 15) . | Furosemide group (n = 15) . | Total (n = 30) . | P . |
---|---|---|---|---|
Antibiotic medications, number (%) | ||||
Meropeneme | 13 (86.6) | 12 (80.0) | 28 (93.3) | 0.6 |
Vancomycin | 14 (93.3) | 12 (80.0) | 25 (83.3) | 0.3 |
Antifungal medications, number (%) | ||||
Nystatine | 15 (100) | 15 (100) | 30 (100) | 1 |
Antiviral medications, number (%) | ||||
Ganciclovir | 11 (73.3) | 14 (93.3) | 25 (83.3) | 0.1 |
Transplant medications, number (%) | ||||
Antithymocyte globulin | 15 (100) | 15 (100) | 30 (100) | 1 |
Tacrolimus | 15 (100) | 15 (100) | 30 (100) | 1 |
Inotropes, number (%) | 15 (100) | 15 (100) | 30 (100) | 1 |
5% dextrose in water (500 ml/m2) plus KCl (10 meq/m2) | 15 (100) | 15 (100) | 30 (100) | 1 |
Drugs . | CRRT group (n = 15) . | Furosemide group (n = 15) . | Total (n = 30) . | P . |
---|---|---|---|---|
Antibiotic medications, number (%) | ||||
Meropeneme | 13 (86.6) | 12 (80.0) | 28 (93.3) | 0.6 |
Vancomycin | 14 (93.3) | 12 (80.0) | 25 (83.3) | 0.3 |
Antifungal medications, number (%) | ||||
Nystatine | 15 (100) | 15 (100) | 30 (100) | 1 |
Antiviral medications, number (%) | ||||
Ganciclovir | 11 (73.3) | 14 (93.3) | 25 (83.3) | 0.1 |
Transplant medications, number (%) | ||||
Antithymocyte globulin | 15 (100) | 15 (100) | 30 (100) | 1 |
Tacrolimus | 15 (100) | 15 (100) | 30 (100) | 1 |
Inotropes, number (%) | 15 (100) | 15 (100) | 30 (100) | 1 |
5% dextrose in water (500 ml/m2) plus KCl (10 meq/m2) | 15 (100) | 15 (100) | 30 (100) | 1 |
CRRT: continuous renal replacement therapy; KCI: potassium chloride
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.